Barrier tissue dysfunction is a fundamental feature of chronic human inflammatory diseases
1. Specialized subsets of epithelial cells—including secretory and ciliated cells—differentiate …

Background Aspirin desensitization followed by high-dose aspirin therapy is routinely performed
for patients with aspirin-exacerbated respiratory disease (AERD). Little is known about …

Allergists and clinical immunologists around the world are increasingly faced with the task
of addressing drug allergy and hypersensitivity due to the increase in drug reactions. …

Background Mast cells are present in the airways of patients who have severe asthma despite
glucocorticoid treatment; these cells are associated with disease characteristics including …

Background Prostaglandin (PG) D 2 is the dominant COX product of mast cells and is an
effector of aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory …

Aspirin-exacerbated respiratory disease (AERD) is characterized by the clinical triad of
chronic rhinosinusitis with nasal polyps, asthma, and an intolerance to medications that inhibit …

… Correspondence and requests for reprints should be addressed to Katherine N. Cahill,
MD, Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical …

Aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) are some of the most common
culprits of drug-induced hypersensitivity reactions, and can lead to a wide array of adverse …

Aspirin-exacerbated respiratory disease (AERD) is the triad of chronic rhinosinusitis with
nasal polyposis, asthma, and adverse reactions to aspirin and other cyclooxygenase-1 (COX1) …

Monoclonal antibodies are important therapeutic tools, but their usefulness is limited in
patients who experience acute infusion reactions, most of which are consistent with type I …